Skip to main content

Low-Frequency Ultrasound Attacks Oral Cancer Cells

Ultrasound waves stopped cancer cell spread and reduced the number of tumor-protective cells in vitro, highlighting the utility of the non-invasive therapy.

Written bySneha Khedkar
| 4 min read
Physiotherapist using shockwave with virtual health care symbol and pain icons medical on interface, signifying ultrasound-mediated cancer therapy.
Register for free to listen to this article
Listen with Speechify
0:00
4:00

When Ajay Tijore was a postdoctoral researcher in mechanobiologist Michael Sheetz’s lab at the National University of Singapore, he and his team studied how mechanical strain affected cancer cells. A few years ago, the researchers found that low-frequency ultrasound waves triggered mechanical stress that killed several invasive cancer cell types.1 “That was kind of a big revelation…[a] Eureka moment,” said Tijore.

When he started his own lab at the Indian Institute of Science in 2021, Tijore hoped to contribute to Indian society. With India accounting for one-third of the oral cancer cases worldwide, Tijore sought to investigate whether low-frequency ultrasound could also target oral cancer cells.2

Rashmita Luha and Ajay Tijore stand in a lab wearing white lab coats.

Study coauthors Rashmita Luha and Ajay Tijore tested the potential of low-frequency ultrasound to selectively kill patient-derived oral cancer cells.

Siddhesh Saiganonkar, Indian Institute of Science

Now, Tijore and his team found that patient-derived oral cancer cells are susceptible to low-frequency ultrasound due to their distinct biomechanical properties compared to healthy cells.3 The team’s findings, published in Materials Today Bio, highlight the potential of the non-invasive approach in oral cancer therapy.

“[This] is a good paper [with] in vitro data,” said Anutosh Ganguly, whose research at the University of Michigan involves ultrasound-mediated tumor ablation and was not involved with the study. “It raises more questions to be answered, but it is the first step.”

Ultrasound Disrupts Oral Cancer Cell Migration

Tijore and his team began by isolating oral cancer cells from patient-derived tumor samples. They then subjected the cells to low-frequency ultrasound using a custom-made device.4 The frequency of this type of ultrasound is about 40 kilohertz, while the frequency of ultrasound routinely used in clinics for diagnostic scans ranges from two to 18 megahertz.

Continue reading below...

Like this story? Sign up for FREE Cancer updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

While this did not affect healthy control cells, ultrasound mechano-stimulation inhibited the spreading of the cancer cells. To investigate the molecular mechanism underlying this, the researchers examined the cells’ focal adhesions. These multi-protein complexes physically link the cell’s cytoskeleton to its extracellular matrix and promote cell spreading. They observed that ultrasound reduced focal adhesion proteins, indicating that it potentially reduces cancer cell spreading by disassembling focal adhesions.

Tijore and his team also assessed the effect of ultrasound on cancer cell migration using in vitro assays. Compared to untreated cells, ultrasound-treated cells showed reduced cell migration. Treated cells also showed less invasion capacity compared to untreated cells when placed in collagen, suggesting that ultrasound suppresses cancer cell migration and invasion.

Next, the researchers sought to understand the properties underlying why ultrasound specifically resulted in cancer cell apoptosis. Researchers have previously shown that depletion of tropomyosin 2.1 (Tmp2.1), a mechanosensory protein that regulates traction forces in cells, makes them vulnerable to ultrasound-mediated apoptosis, or mechanoptosis.5

Immunofluorescence and immunoblotting revealed that oral cancer cells expressed less Tmp2.1 compared to control cells, suggesting that Tpm2.1 depletion in oral cancer cells could render them mechanically vulnerable.

Loosening the Tumor Barrier Could Enhance Chemotherapy Efficacy

Finally, Tijore and his team investigated the translational applications of their findings. Patients with oral cancer often exhibit stiffness around their tumor, said Tijore, which forms due to cancer cells recruiting fibroblasts to themselves. These cancer-associated fibroblasts envelope the tumor core, acting as a barrier that prevents chemotherapeutic drugs or immunotherapeutic cells from infiltrating the tumor, which drives resistance to therapies.

A microscopy image showing some green cells surrounded by dense, magenta cells on the left, signifying control treatment group, with the pink cells reducing in numbers on the right, signifying ultrasound-treated cells.

Fluorescence microscopy revealed that ultrasound treatment reduced cancer-associated fibroblasts (magenta) cocultured with patient-derived oral cancer cells (green).

Rashmita Luha, Indian Institute of Science

Consistent with this, the researchers observed cancer-associated fibroblasts blanketing tumor cells upon visualizing patient-derived tumor samples using immunohistochemistry. To mimic this tumor microenvironment in vitro, Tijore and his team cocultured patient-derived tumor cells with cancer-associated fibroblasts. They found that ultrasound reduced the infiltration of cancer-associated fibroblasts, exposed the tumor core, and highlighted that ultrasound mechano-stimulation could loosen the barrier enveloping the tumor to enhance drug permeability.

This was “striking,” said Tijore, because this finding indicated that ultrasound could potentially help improve the effectiveness of existing therapies.

According to Ganguly, the focal adhesion dynamics that the researchers uncovered are interesting. “This is a good first start,” he said. However, he noted that although the results reveal that loss of Tmp2.1 renders the cells vulnerable to ultrasound-mediated death, the exact cell death pathway remains unclear.

While researchers can study this process in vitro, the “future work is [to see] how we can make this translational,” said Ganguly. The next step would be to conduct experiments in vivo, he explained.

Studying the effect of ultrasound on patient-derived oral cancer organoids or animal models would come next, agreed Tijore. “We have already gotten ethical approval from the institute to perform animal studies,” he added.

Looking back, Tijore said that the most satisfying aspect of working on this project was receiving emails and phone calls from patients and hospitals volunteering to participate in clinical studies after reading the paper. This has motivated the team to work harder to get a clearer picture of the efficacy and safety of ultrasound mechano-stimulation in vivo. “The most exciting [part] is that when as a researcher, you find that some discovery or some technology [that] you are developing is going to help society,” said Tijore.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Sneha Khedkar

    Sneha Khedkar is an Assistant Editor at The Scientist. She has a Master’s degree in biochemistry, after which she studied the molecular mechanisms of skin stem cell migration during wound healing as a research fellow at the Institute for Stem Cell Science and Regenerative Medicine in Bangalore, India. She has previously written for Scientific American, New Scientist, and Knowable Magazine, among others.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo